Low-Risk Thyroid Cancer in Adults: Update on Management

Most patients with differentiated thyroid cancer fall into low-risk stages, where survival is >90%. Therefore, for these patients, initial stratification for risk of structural disease recurrence should be the primary determinant for therapeutic decision-making about surgery, radioiodine, and TSH suppression.

After primary therapy, surveillance data from serum thyroglobulin testing and ultrasound imaging can be used to guide long-term follow-up.